A device for extracorporeal blood treatment, in particular a dialysis device, including an internal fluidic system for a treatment liquid, in particular for a dialysis liquid, the internal fluidic system having at least two liquid connectors for connecting a substantially cylindrical filter element, in particular a dialyzer, to the internal fluidic system for passing a treatment liquid through the filter element, and including a mounting for exchangeably holding the filter element in such a way that the filter element can be connected to the liquid connectors of the internal fluidic system and to an extracorporeal blood line in an intended manner, wherein the mounting for holding the filter element is designed in such a way that a cylinder longitudinal axis of the filter element is substantially horizontally aligned.

A method of preparing a solution for use during a dialysis, hemodialysis, or Continuous Renal Replacement Therapy (CRRT) treatment of a patient is provided. An antibiotic or other drug is added (48, 50, 52) to a solution and the concentration or dosing of the antiboitic or other drug within the solution is adjusted (72) as required based on a determiniation (64) of serum level of the antibiotic in a blood sample of a patient.

A safety needle is disclosed having a puncture needle with a needle lumen and a ground tip; a holding device that, during use, bears on the skin of a patient and holds the puncture needle; and a safety mechanism with a protection element that has a first, opened state and a second, closed state. When the holding device is taken away from the skin and/or when the holding device is moved with respect to the defined position, the safety mechanism automatically moves the protection element from a first position, in which the tip of the needle is exposed, to a second position, in which the tip of the needle is covered as the protection element at the same time transfers automatically from the first, opened state to the second, closed state.

The present invention relates to a medical solution. According to the invention the ready-for-use solution comprises phosphate in a concentration of 1.0-2.8 mM, is sterile and has a pH of 6.5-7.6. The present invention further relates to a method for producing the medical solution and the use thereof.

The present invention relates to a dialysis machine having two hydraulic connectors at the dialyzate side to which a respective connection line having a filter coupling is connected for connection to a dialyzer, with the hydraulic connectors being an inflow connector for feeding fresh dialysis liquid to the dialyzer and a backflow connector for draining consumed dialyzate from the dialyzer, and having two parking positions associated with the respective hydraulic connectors for storing the filter couplings when not in operation, wherein the filter couplings of both hydraulic connectors are equipped with a connection sensor which recognizes a connecting of the filter coupling to a dialyzer and/or that both parking positions are provided with separate covers.

The present invention provides a method for hemodiafiltration which applies dialysate gradient across a multi-chambered hemodiafiltrator having a plurality of compartmentalized tubular dialysate chambers. An acidic dialysate with urea at a concentration is applied to a first dialysate chamber. A less acidic dialysate with a lower concentration of urea than those for the first dialysate chamber is applied to a second dialysate chamber. A basic dialysate with no urea but with ammonia at a concentration up to a concentration detected in normal human blood is applied to a last dialysate chamber. The concentrations of urea for the first and second dialysate chambers decrease over time to zero prior to conclusion of hemodiafiltration.

The present invention relates to sol gel hydrous metal oxide particles, such as hydrous zirconium oxide particles, their manufacture, and their use in such applications as sorbent dialysis.

The invention relates to a device for discharging wastewater, in particular used or spent dialysate, comprising a plurality of line connections 3, 4, 5 for connecting wastewater lines, in particular wastewater lines of dialysis machines. The device according to the invention is designed as a part which can stand on the bottom of a basin. Sufficient stability can be achieved on account of the weight (gravitational force) of the device alone, without it being necessary to secure the device. Recontamination is prevented effectively in that the line connections 3, 4, 5 are in fluid connection with at least one inflow line, the lower end of which is arranged so as to be spaced apart from the bottom, such that a free-fall distance is formed. In a preferred embodiment, a casing 1 surrounds the at least one inflow line 6, 7, 8.

The casing 1 forms a splash guard in the form of a hood such that the wastewater, which emerges from the inflow lines 6, 7, 8 under relatively high pressure, cannot reach the surroundings.

The present invention relates to a dialysis solution containing bicarbonate, calcium and phosphate, wherein the dialysis solution contains phosphate having a concentration in the range from up to 0.4 mmol/l, preferably in the range from up to 0.375 mmol/l, or in the range from up to 0.25 mmol/l, and particularly preferably in the range from up to 0.2 mmol/l.

Methods and for treatment of cancer and other diseases including complications from late stage viral infections by inducing hyperthermia in a patient relying on withdrawing blood from the patient and returning the withdrawn blood to the patient to establish an extracorporeal flow circuit. Blood is heated by passing through the extracorporeal circuit at a controlled rate until a target body core temperature in is achieved. Usually, the blood will be subjected to a continuously re-circulating dialysis to balance electrolytes. Additionally, the blood will be subjected to a continuously recirculating regeneration through a carbon sorbent column where toxins and contaminants are removed. The blood temperature is maintained at the target blood temperature for a treatment period, and the blood is cooled after the treatment period has been completed. The method can also be effective in treating rheumatoid arthritis, scleroderma, hepatitis, sepsis, the Epstein-Barr virus, and patients with life threatening complications from other viruses, including the COVID-19 virus. A method for removing viruses from the blood supply in an external circuit is also presented.